Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_provenance.
- NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_assertion description "[The small molecule ET(A)R antagonist achieves concomitant suppression of tumor growth and EMT effectors, providing a new opportunity for therapeutic intervention in which targeting ILK pathway and the related Snail and beta-catenin signaling cascade via ET(A)R blockade may be advantageous in the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_provenance.
- NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_assertion evidence source_evidence_literature NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_provenance.
- NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_assertion SIO_000772 17587812 NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_provenance.
- NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_assertion wasDerivedFrom befree-20140225 NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_provenance.
- NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_assertion wasGeneratedBy ECO_0000203 NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP788133.RAkTRZq_BLD7q0tCcrrMvRwEAvP6thHJMlA8Hmu48tivo130_provenance.